Critically ill patients may die despite aggressive treatment. In this study, we examine trends in the application of two such treatments over a decade, as well as the impact of these trends on survival durations in patients who die within a month of ICU admission. We considered observational data available from the MIMIC-III open-access ICU database, collected from June 2001 to October 2012: These data comprise almost 60,000 hospital admissions for a total of 38,645 unique adults .
Introduction
Critically ill patients commonly receive aggressive treatments including mechanical ventilation and continuous intravenous cardioactive agents. These kinds of treatments may be administered even to patients with very poor prognosis in an attempt to keep them alive for as long as possible. However, these treatments are supportive rather than curative. Many if not most of patients so identified will not survive beyond a relatively short term, and are among the more than 1 in 5 patients in the US who die after receiving what proved to be "non-beneficial" care in the intensive care unit (ICU) 1 . Mechanical ventilation at the end of life deprives patients of the ability to speak with family and friends, which may severely diminish the patient's quality of life in their final moments, and may engender distress among their surviving family and friends. However, little is known about how rates of aggressive treatments for end-of-life patients in the ICU have changed over time, or the impact of any such changes on how long these patients ultimately live.
To explore these questions, we examined trends in the application of aggressive ICU treatments at one institution over the course of ten years. We hypothesized that rates of aggressive treatment for patients who died during or soon after an ICU stay would decrease because of the introduction of efforts to improve end-of-life communication and care in the ICU. We also hypothesized that with these life-sustaining treatments withheld or discontinued, these patients would likely die sooner. Importantly, the end of aggressive treatments in these patients did not indicate the end of medical and nursing care. Rather, they were replaced by measures for symptom control and comfort measures at the end of life. Study procedure. We explored the following hypotheses: (i) administration of aggressive treatment during the ICU stay immediately preceding end-of-life would decrease over the study time period and (ii) time-to-death from ICU admission would also decrease due to the decrease in aggressive treatment administration. Aggressive treatment was defined by the following variables: vasopressor administration, which required insertion of a central intravenous access (as both binary variable yes/no and duration) and mechanical ventilation (as both binary variable yes/no and duration). Time-to-death was computed from the time of ICU admission. The following variables were extracted to adjust for confounding: age at admission, gender (binary variable, male or female), Simplified Acute Physiology Score or SAPS II 3 , and Elixhauser Comorbidity Index score 4 and Do Not Resuscitate (DNR) status at admission. All data extraction queries were performed using PostgreSQL (https://www.postgresql.org). We analyzed trends for the entire cohort of patients, and for subgroups with highest and lowest acuity score, to assess if any effect would be more pronounced for the sickest patients. A p-value threshold of 0.05 was used to assess statistical significance.
Methods

Results
Characteristics for our cohort of 6,436 patients across ten years are reported in Table   1 . Age at admission, gender and SAPS II scores were similar during the study period, showing overall comparable clinical conditions for the patients admitted to the ICUs during those ten years. The single exception was a significantly increasing trend for Elixhauser scores, indicating that the patient population had more co-morbidities and likely a higher level of prior-to-admission clinical severity (Table 1) . Over the study period, we observe a significantly decreasing trend in the administration of aggressive treatments (use of vasopressors and mechanical ventilation, see also Table 2 ), which was consistent with our first hypothesis. But contrary to our second hypothesis, we found no change in median time-to-death from admission to the ICU (Table 1) .
To further investigate the second hypothesis, we conducted an additional exploratory subgroup analysis to examine whether we could identify a subset of patients who actually survived longer when aggressive interventions were withheld. We stratified the patients based on their SAPS II scores, and then focused on the patients within the first and the third tertiles. The patients in the first tertile represent the lowest acuity, while the patients in the third tertile represent the highest acuity. We then repeated our analysis in these two subsets.
Note that 'lowest' acuity is a relative term, as all these patients ultimately died within 30 days of ICU admission, and therefore had absolute severities higher than the general ICU population would manifest.
The results for the lowest acuity patients resembled the trends observed in the whole population. However, the highest acuity patients show slightly different results; mechanical ventilation use followed a similar decreasing trend as the overall group, but the use of vasopressors remained constant (i.e. no statistical difference) during the study period.
Time-to-death remained unchanged in both groups. To more clearly present the findings within the subgroups, we show average results of these two groups of patients during a period of the earliest years (2002 to 2005) and the most recent years (2008 to 2012) ( Table   2 ).
Discussion
While clinicians cannot predict whether a patient will die before a certain time, they can identify patients with particularly poor prognosis. We included such patients by extracting data from the ICU subpopulation that did not survive more than a month past ICU admission to derive insight into the impact of aggressive interventions on their eventual outcomes. Though observational, our analyses of time trends in one large institution suggest that in accordance with our hypothesis, these interventions are being employed less frequently in this group. However, contrary to our hypothesis, reducing aggressive treatments for critically ill patients does not result in a shorter time to death. Therefore, there may not be an unacceptable trade-off between longevity and quality of life for this patient population at the end of life: patients identified as very high risk to die within a short time interval (i.e. 30 days after admission) who do not receive aggressive treatment may live just as long as those who do not receive such treatments.
To our knowledge, this is the first investigation into trends of aggressive treatment for end-of-life care and the impact of their utilization on time to death. However such findings are not without precedent. One study of palliative care patients found that such care can result in reduced use of aggressive treatments and higher quality of life in terminal metastatic non-small cell lung cancer patients 7 . Other studies 8 have found reduced lengths of stay in an ICU after a separate palliative care unit was opened. The use of non-invasive ventilation increased during the study interval and may account for some (or all) of the survival observed in patients in whom mechanical ventilation was discontinued 9 . It is less clear why the discontinuation of vasopressor support should result in little survival change.
Perhaps when mechanical ventilation was not initiated or discontinued, the cardiovascular system may benefit from removal of the adverse effects of positive pressure ventilation on cardiovascular physiology. It is also possible that the clinicians are more likely to accept values outside the "norm" for blood pressure and/or oxygen saturation that they would.
Our analysis has several important limitations. This is an observational study and therefore may not imply causality. In addition, it is a single center study, and there may be additional confounders for which we did not adjust. Still, these results raise important questions about current approaches to aggressive treatment in patients who are likely to be near the end of life. Despite the expectation that patients would die sooner if aggressive interventions were withheld or discontinued sooner, we found no such association. Although it is likely that some individuals died more quickly because mechanical ventilation and/or vasopressor were not administered, for other patients, such aggressive treatments may even act to hasten their deaths. Therefore, the assumption that aggressive treatment is always life sustaining in this context may be incorrect.
Further research is needed to corroborate these findings. If the findings hold, the use of aggressive treatments in the ICU for poor prognosis patients who are not responding to ICU care should be fundamentally reconceptualized as a high-risk form of treatment, and tools and interventions will be needed to help ICU clinicians determine which patients will likely benefit from aggressive treatments, which are not likely to benefit, and which may actually be harmed by them. For clinicians carrying on end of life discussions with patients and families regarding using, withholding or discontinuing aggressive therapies, our findings should provide useful information in terms of the likely impact of such decisions on remaining survival durations. 
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